393 related articles for article (PubMed ID: 11176068)
21. Expression profiles of melanogenesis-related genes and proteins in acquired melanocytic nevus.
Hashimoto Y; Ito Y; Kato T; Motokawa T; Katagiri T; Itoh M
J Cutan Pathol; 2006 Mar; 33(3):207-15. PubMed ID: 16466507
[TBL] [Abstract][Full Text] [Related]
22. Absence of TRP-2 in melanogenic melanocytes of human hair.
Commo S; Gaillard O; Thibaut S; Bernard BA
Pigment Cell Res; 2004 Oct; 17(5):488-97. PubMed ID: 15357835
[TBL] [Abstract][Full Text] [Related]
23. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.
Boyle JL; Haupt HM; Stern JB; Multhaupt HA
Arch Pathol Lab Med; 2002 Jul; 126(7):816-22. PubMed ID: 12088451
[TBL] [Abstract][Full Text] [Related]
24. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
Chen YT; Stockert E; Tsang S; Coplan KA; Old LJ
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8125-9. PubMed ID: 7667256
[TBL] [Abstract][Full Text] [Related]
25. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
Orchard GE
Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
[TBL] [Abstract][Full Text] [Related]
26. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.
Du J; Widlund HR; Horstmann MA; Ramaswamy S; Ross K; Huber WE; Nishimura EK; Golub TR; Fisher DE
Cancer Cell; 2004 Dec; 6(6):565-76. PubMed ID: 15607961
[TBL] [Abstract][Full Text] [Related]
27. Microphthalmia-associated transcription factor (MITF) is required but is not sufficient to induce the expression of melanogenic genes.
Gaggioli C; Buscà R; Abbe P; Ortonne JP; Ballotti R
Pigment Cell Res; 2003 Aug; 16(4):374-82. PubMed ID: 12859621
[TBL] [Abstract][Full Text] [Related]
28. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
[TBL] [Abstract][Full Text] [Related]
29. UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes.
Seo EY; Jin SP; Sohn KC; Park CH; Lee DH; Chung JH
J Invest Dermatol; 2017 Aug; 137(8):1757-1765. PubMed ID: 28392346
[TBL] [Abstract][Full Text] [Related]
30. Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.
Ringhoffer M; Schmitt M; Karbach J; Jäger E; Oesch F; Arand M
Int J Oncol; 2001 Nov; 19(5):983-9. PubMed ID: 11604998
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor.
Jiménez-Cervantes C; Martínez-Esparza M; Pérez C; Daum N; Solano F; García-Borrón JC
J Cell Sci; 2001 Jun; 114(Pt 12):2335-44. PubMed ID: 11493672
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional repression of the microphthalmia gene in melanoma cells correlates with the unresponsiveness of target genes to ectopic microphthalmia-associated transcription factor.
Vachtenheim J; Novotna H; Ghanem G
J Invest Dermatol; 2001 Dec; 117(6):1505-11. PubMed ID: 11886515
[TBL] [Abstract][Full Text] [Related]
33. Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines.
Hertzman Johansson C; Azimi A; Frostvik Stolt M; Shojaee S; Wiberg H; Grafström E; Hansson J; Egyházi Brage S
Melanoma Res; 2013 Oct; 23(5):360-5. PubMed ID: 23921446
[TBL] [Abstract][Full Text] [Related]
34. [Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor].
Denat L; Larue L
Bull Cancer; 2007 Jan; 94(1):81-92. PubMed ID: 17237008
[TBL] [Abstract][Full Text] [Related]
35. Microphthalmia transcription factor analysis in posterior uveal melanomas.
Mouriaux F; Vincent S; Kherrouche Z; Maurage CA; Planque N; Monté D; Labalette P; Saule S
Exp Eye Res; 2003 Jun; 76(6):653-61. PubMed ID: 12742347
[TBL] [Abstract][Full Text] [Related]
36. Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens.
Lim E; Browning J; MacGregor D; Davis ID; Cebon JS
Melanoma Res; 2006 Aug; 16(4):347-55. PubMed ID: 16845331
[TBL] [Abstract][Full Text] [Related]
37. Expression of gp100 and CDK2 in melanoma cells is not co-regulated by a shared promoter region.
Stennett LS; Riker AI; Kroll TM; ChaMberlin J; Miki T; Nickoloff BJ; Le Poole IC
Pigment Cell Res; 2004 Oct; 17(5):525-32. PubMed ID: 15357840
[TBL] [Abstract][Full Text] [Related]
38. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.
Chi DD; Merchant RE; Rand R; Conrad AJ; Garrison D; Turner R; Morton DL; Hoon DS
Am J Pathol; 1997 Jun; 150(6):2143-52. PubMed ID: 9176405
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
[TBL] [Abstract][Full Text] [Related]
40. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
Clarkson KS; Sturdgess IC; Molyneux AJ
J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]